Mequon, Wis.-based Titan Spine reached an 18,000 implantation milestone for its Endoskeleton interbody fusion device. The company is approaching an annualized sales revenue run-rate of $20 million.
Titan Spine has been growing steadily over the past 12 months, and recently signed a distribution agreement with Biomet.
More Articles on Devices:
Mitek Sports Medicine Launches RIGIDFIX ACL Reconstruction System
Alphatec Spine Loses $14.5M in Q3 After PurGen Device Discontinuation
DMP Spine Biologics to Distribute Bacterin Bone Graft Products in Europe